Evidence map›Paper›PMID 29653046›Full record

ArticleACS chemical biology2018

Mechanism of Action of the Cytotoxic Asmarine Alkaloids.

Michael J Lambrecht, Jeffery W Kelly, Ryan A Shenvi

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. PEtTetrahedron · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael J LambrechtDepartment of Chemistry and Department of Molecular Medicine , The Scripps Research Institute , La Jolla , California 92037 , United States.
Jeffery W KellyDepartment of Chemistry and Department of Molecular Medicine , The Scripps Research Institute , La Jolla , California 92037 , United States.ORCID 0000-0001-8943-3395
Ryan A ShenviDepartment of Chemistry and Department of Molecular Medicine , The Scripps Research Institute , La Jolla , California 92037 , United States.ORCID 0000-0001-8353-6449
Scripps Research Institute · US

Funding

Unusual Pharmacophores and New Tools for Cross-CouplingR35GM122606 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI Ryan Ashok Shenvi · 2017 to 2026
$7.1M
NIGMS NIH HHS R35 GM122606
6 · The paper itself

Abstract

The asmarines are a family of cytotoxic natural products whose mechanism of action is unknown. Here, we used chemical synthesis to reverse engineer the asmarines and understand the functions of their individual components. We found that the potent asmarine analog "delmarine" arrested the mammalian cell cycle in the G1 phase and that both cell cycle arrest and cytotoxicity were rescued by cotreatment with ferric and ferrous salts. Cellular iron deprivation was clearly indicated by changes in iron-responsive protein markers, and cytotoxicity occurred independently of radical oxygen species (ROS) production. Chemical synthesis allowed for annotation of the distinct structural motifs required for these effects, especially the unusual diazepine, which we found enforced an iron-binding tautomer without distortion of the NCNO dihedral angle out of plane. With this information and a correlation of cytotoxicity with logP, we could replace the diazepine by lipophilic group appendage to N9, which avoided steric clash with the N6-alkyl required to access the aminopyridine. This study transformed the asmarines, scarce marine metabolites, into easily synthesized, modular chemotypes that may complement or succeed iron-selective binders in clinical trials and use.

Indexed as

Cell Cycle CheckpointsCell Line, TumorCell SurvivalDiterpene AlkaloidsDNA ReplicationFlow CytometryG1 PhaseHumansReactive Oxygen SpeciesSpectrophotometry, UltravioletStructure-Activity RelationshipDiterpene AlkaloidsReactive Oxygen Species

Identifiers

PMID29653046
PMCPMC5959788
OpenAlexW2797513037

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.